Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Vaishali Pharma's
Operating Income
for the
three
months ended in Mar. 2025 was ₹1.3 Mil. Vaishali Pharma's Interest Expense for the
three
months ended in Mar. 2025 was ₹-9.3 Mil.
Vaishali Pharma's interest coverage for the quarter that ended in Mar. 2025 was 0.14.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Vaishali Pharma's Interest Coverage or its related term are showing as below:
NSE:VAISHALI's Interest Coverage is not ranked *
in the Drug Manufacturers industry.
Industry Median: 13.91 * Ranked among companies with meaningful Interest Coverage only.
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Vaishali Pharma Interest Coverage Related Terms
Vaishali Pharma Interest Coverage Historical Data
* Premium members only.
The historical data trend for Vaishali Pharma's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Drug Manufacturers - Specialty & Generic subindustry, Vaishali Pharma's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vaishali Pharma Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vaishali Pharma's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Vaishali Pharma's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vaishali Pharma (NSE:VAISHALI) has a Interest Coverage of 0.14 as of Mar. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Vaishali Pharma and its competitors.
Is Vaishali Pharma's Interest Coverage too high?
Vaishali Pharma's current Interest Coverage is 0.14. The Drug Manufacturers industry median Interest Coverage is 13.91. Vaishali Pharma's value of 0.14 is 99% below this industry median. Overall, Vaishali Pharma has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Vaishali Pharma's Interest Coverage compare to ZTS?
Vaishali Pharma's Interest Coverage of 0.14 can be compared against companies in the Drug Manufacturers industry. The industry median Interest Coverage is 13.91. Vaishali Pharma's value of 0.14 is 99% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 13.91, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vaishali Pharma's current Interest Coverage of 0.14 is 99% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Vaishali Pharma and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 13.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vaishali Pharma's current Interest Coverage is 0.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaishali Pharma stock overvalued right now?
Vaishali Pharma (NSE:VAISHALI) has a current Interest Coverage of 0.14. The current Interest Coverage is 0.14 and 99% below the Drug Manufacturers industry median of 13.91. Vaishali Pharma's overall GF Score™ is 52/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Vaishali Pharma (NSE:VAISHALI), the current Interest Coverage is 0.14 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vaishali Pharma Ltd is a pharmaceutical company. The Company is engaged in the marketing of pharmaceutical products including active pharmaceutical ingredients.
52GF Score
Get the complete analysis for NSE:VAISHALI
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:VAISHALI has been successfully added to your 
